Abbott Laboratories logo

Abbott Laboratories (ABTCL)

Market Closed
3 Jul, 19:00
XSGO XSGO
108,200. 00
CLP
0
0%
CLP
- Market Cap
36.49 P/E Ratio
2.2% Div Yield
0 Volume
4.44 Eps
108,200 CLP
Previous Close
Day Range
108,200 108,200
Year Range
95,000 126,000
Want to track ABTCL and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 11 days

Summary

ABTCL closed yesterday higher at 108,200 CLP, an increase of 0% from Wednesday's close, completing a monthly increase of 0% or 0 CLP. Over the past 12 months, ABTCL stock gained 0%.
ABTCL pays dividends to its shareholders, with the most recent payment made on May 15, 2025. The next announced payment will be in In 1 month on Aug 15, 2025 for a total of 0.59 CLP.
The last earnings report, released on Apr 15, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports. The next scheduled earnings report is due on Jul 16, 2025.
Abbott Laboratories has completed 8 stock splits, with the recent split occurring on Jan 02, 2013.
The company's stock is traded on 16 different exchanges and in various currencies, with the primary listing on NYSE (USD).

ABTCL Chart

Chart

Empty chart
The chart has 2 Y axes displaying values, and values.
Loading, please wait...
End of interactive chart.
Is It Worth Investing in Abbott (ABT) Based on Wall Street's Bullish Views?

Is It Worth Investing in Abbott (ABT) Based on Wall Street's Bullish Views?

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?

Zacks | 12 hours ago
Abbott (ABT) Stock Drops Despite Market Gains: Important Facts to Note

Abbott (ABT) Stock Drops Despite Market Gains: Important Facts to Note

In the closing of the recent trading day, Abbott (ABT) stood at $134.11, denoting a -1.58% move from the preceding trading day.

Zacks | 2 days ago
Abbott (ABT) Upgraded to Buy: Here's What You Should Know

Abbott (ABT) Upgraded to Buy: Here's What You Should Know

Abbott (ABT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Zacks | 2 days ago

Abbott Laboratories Dividends

Abbott Laboratories logo
ABT In 1 weeks
Announced
Quarterly
$0.59 Per Share
Abbott Laboratories logo
ABT 2 months ago
Paid
Quarterly
$0.59 Per Share
Abbott Laboratories logo
ABT 5 months ago
Paid
Quarterly
$0.59 Per Share
Abbott Laboratories logo
ABT 8 months ago
Paid
Quarterly
$0.55 Per Share
Abbott Laboratories logo
ABT 11 months ago
Paid
Quarterly
$0.55 Per Share

Abbott Laboratories Earnings

17 Jul 2025 (In 1 week) Date
1.25
Cons. EPS
-
EPS
16 Jul 2025 (In 1 week) Date
1.25
Cons. EPS
-
EPS
15 Apr 2025 Date
-
Cons. EPS
-
EPS
22 Jan 2025 Date
1.34
Cons. EPS
1.34
EPS
16 Oct 2024 Date
1.2
Cons. EPS
1.21
EPS
Abbott Laboratories logo
ABT In 1 weeks
Announced
Quarterly
$0.59 Per Share
Abbott Laboratories logo
ABT 2 months ago
Paid
Quarterly
$0.59 Per Share
Abbott Laboratories logo
ABT 5 months ago
Paid
Quarterly
$0.59 Per Share
Abbott Laboratories logo
ABT 8 months ago
Paid
Quarterly
$0.55 Per Share
Abbott Laboratories logo
ABT 11 months ago
Paid
Quarterly
$0.55 Per Share
17 Jul 2025 (In 1 week) Date
1.25
Cons. EPS
-
EPS
16 Jul 2025 (In 1 week) Date
1.25
Cons. EPS
-
EPS
15 Apr 2025 Date
-
Cons. EPS
-
EPS
22 Jan 2025 Date
1.34
Cons. EPS
1.34
EPS
16 Oct 2024 Date
1.2
Cons. EPS
1.21
EPS

Abbott Laboratories (ABTCL) FAQ

What is the stock price today?

The current price is 108,200.00 CLP.

On which exchange is it traded?

Abbott Laboratories is listed on NYSE.

What is its stock symbol?

The ticker symbol is ABTCL.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 2.2%.

What is its market cap?

As of today, no market cap data is available.

What is the earnings per share?

The EPS is 1.25.

When is the next earnings date?

The next earnings report will release on Jul 16, 2025.

Has Abbott Laboratories ever had a stock split?

Abbott Laboratories had 8 splits and the recent split was on Jan 02, 2013.

Abbott Laboratories Profile

Medical - Devices Industry
Healthcare Sector
Robert B. Ford CEO
XSGO Exchange
US0028241000 ISIN
US Country
114,000 Employees
15 Jul 2025 Last Dividend
2 Jan 2013 Last Split
13 Jan 1978 IPO Date

Overview

Abbott Laboratories is a global healthcare company that engages in the discovery, development, manufacturing, and sale of a wide range of health care products. With its foundation laid in 1888, and headquartered in North Chicago, Illinois, the company has established a significant presence worldwide. Abbott operates across four main sectors: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices, catering to a diverse range of healthcare needs from generic pharmaceuticals to advanced medical devices.

Products and Services

Abbott Laboratories offers a comprehensive portfolio of products and services across various healthcare domains:

  • Generic Pharmaceuticals: Includes treatments for pancreatic exocrine insufficiency, irritable bowel syndrome, biliary spasm, intrahepatic cholestasis, depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease, vestibular vertigo, pain, fever, inflammation, migraine, anti-infective clarithromycin, influenza vaccine, and colon rhythm regulation products.
  • Diagnostic Products: Offers laboratory and transfusion medicine systems in areas such as immunoassay, clinical chemistry, hematology, and transfusion. Includes molecular diagnostics for DNA and RNA processing and detection of infectious agents, point-of-care systems, blood gas testing cartridges, rapid diagnostics, molecular point-of-care testing for several diseases, cardiometabolic tests, drug and alcohol tests, remote patient monitoring, consumer self-tests, and laboratory automation and informatics solutions.
  • Nutritional Products: Provides nutritional products for both pediatric and adult use, catering to the specific dietary needs of different age groups and health conditions.
  • Medical Devices: Offers a wide array of devices for the treatment of cardiovascular diseases, including rhythm management, electrophysiology, heart failure, vascular, and structural heart devices. Additionally, the company develops diabetes care products such as blood glucose monitoring systems, along with neuromodulation devices for managing chronic pain and movement disorders.

Contact Information

Address: 100 Abbott Park Road
Phone: 224 667 6100